MYC and neoplasm: Analysis of bulk RNA-seq data on CKI-treated MDA-MB-231 cells displayed that proliferation-related pathways like MYC targets, G2M checkpoint and E2F targets were significantly down-regulated in the CKI-treated tumor cells compared with the control cells.